Aurobindo Pharma arm CuraTeQ Biologics gets positive opinion for breast cancer drug Dazublys from EMA Ruchika Sharma26 April 2025 11:30 AM ISTHyderabad: CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma Limited, has announced that the Committee for...
Aurobindo Pharma arm CuraTeQ Biologics completes successful Phase 1 Pharmacokinetics study of bone drug Ruchika Sharma10 April 2025 11:56 AM ISTDenosumab works by specifically targeting the RANK ligand (RANKL), a critical protein in the lifecycle of osteoclasts, the cells that break down bone.
Aurobindo Pharma arm gets European Commission authorization to market Dyrupeg in EU Ruchika Sharma7 April 2025 2:15 PM ISTTelangana: Aurobindo Pharma has announced that the European Commission (EC) has granted marketing authorization in the European Union (EU)...
Aurobindo Pharma arm gets marketing authorisation for Zefylti in EU Ruchika Sharma18 Feb 2025 1:30 PM ISTHyderabad: Aurobindo Pharma has announced that the European Commission (EC) has granted marketing authorization in the European Union (EU) for ...
Aurobindo Pharma arm gets positive opinion for biosimilar Dyrupeg from EMA Ruchika Sharma1 Feb 2025 11:30 AM ISTHyderabad: CuraTeQ Biologics s.r.o., a step-down subsidiary of Aurobindo Pharma Limited, has announced that the Committee for Medicinal...
Aurobindo Pharma arm CuraTeQ Biologics gets UK MHRA nod for cancer treatment Bevqolva Ruchika Sharma22 Dec 2024 1:30 PM ISTHyderabad: CuraTeQ Biologics s.r.o., a step-down subsidiary of Aurobindo Pharma Limited, has announced that it has obtained marketing...
Aurobindo Pharma arm gets positive opinion from EMA Committee for Zefylti for neutropenia treatment Ruchika Sharma14 Dec 2024 12:30 PM ISTHyderabad: CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has announced that the Committee for...
Aurobindo Pharma arm gets GMP certificate of compliance for biosimilars manufacturing facility from EMA Ruchika Sharma13 Nov 2024 11:45 AM ISTHyderabad: CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has received a GMP certificate of...
Aurobindo Pharma arm announces successful Phase 1 clinical study outcome of their BP11 product Susmita Roy18 March 2024 1:30 PM ISTHyderabad: CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Ltd, has announced that their Omalizumab biosimilar...
Aurobindo Pharma arm bags CDSCO panel recommendation for grant of marketing authorization of biosimilar trastuzumab Ruchika Sharma18 Jan 2024 3:10 PM ISTHyderabad: In a recent BSE filing, Aurobindo Pharma has announced that CuraTeQ Biologics Pvt. Ltd., a wholly owned subsidiary of the...
Aurobindo Pharma arm CuraTeQ Biologics to commercialize proposed biosimilar to Stelara Ruchika Sharma8 July 2023 12:00 PM ISTCuraTeQ intends to file this product in India and Emerging Markets as early as in 2024 and the regulated markets filing is expected to begin in 2026.
Breast cancer biosimilar product meets primary endpoint in Phase 3 clinical trial: Aurobindo Pharma Ruchika Sharma5 July 2023 11:30 AM ISTHyderabad:Aurobindo Pharma Limited has announced that the breast cancer biosimilar product, BP02 (Trastuzumab or biosimilar to Herceptin), developed ...
